Home LiteratureArticle Details
PMID: 15163903 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Tapasin decreases immune responsiveness to a model tumor antigen.

Journal of clinical immunology ·Vol. 24 ·No. 4 ·2004-07-00 ·Pages 462-70

Turnquist HR, Kohlgraf KG, McIlhaney MM, Mosley RL, Hollingsworth MA, Solheim JC

Abstract

The T-cell response against cancer is dependent on the cell surface presentation of tumor-associated or tumor-specific peptides by major histocompatibility complex (MHC) class I molecules. We found that tapasin, a chaperone protein that normally assists in the assembly of MHC class I molecules, is undetectable in an unstimulated pancreatic tumor cell line, Panc02, and only very weakly expressed after gamma-interferon stimulation. Transfection of tapasin into the Panc02 cells did not quantitatively increase MHC class I surface expression or detectably affect MHC class I association with peptide and beta(2)-microglubulin (beta(2)m). However, we found that transfected tapasin downregulated immune reactivity against a model tumor antigen, MUC1. Although tapasin has been previously shown by others to increase immune recognition of particular antigens, our results suggest that tapasin has a negative impact on the presentation of an immunodominant epitope from a specific model tumor antigen.

MeSH Terms
Antibody Formation/drug effects Antigens/immunology Antigens, Neoplasm/immunology Antiporters/genetics,pharmacology Cell Line, Tumor Down-Regulation/drug effects Glycoproteins/immunology Histocompatibility Antigens Class I/genetics Humans Immunodominant Epitopes Immunoglobulins/genetics,pharmacology Membrane Transport Proteins Molecular Chaperones/genetics,pharmacology Mucin-1 Mucins Pancreatic Neoplasms/pathology Transfection
Chemicals
Antigens Antigens, Neoplasm Antiporters Glycoproteins Histocompatibility Antigens Class I Immunodominant Epitopes Immunoglobulins MUC1 protein, human Membrane Transport Proteins Molecular Chaperones Mucin-1 Mucins tapasin
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Turnquist Heth R
Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, 986805 Nebraska Medical Center, Omaha, NE 68198-6805, USA.
Kohlgraf Karl G
McIlhaney Mary M
Mosley R Lee
Hollingsworth Michael A
Solheim Joyce C
References (31)
31 references, click to expand
  1. Induction and chemotherapeutic response of two transplantable ductal adenocarcinomas of the pancreas in C57BL/6 mice.
    Cancer Res. 1984 Feb;44(2):717-26 PMID: 6692374
  2. A sequential model for peptide binding and transport by the transporters associated with antigen processing.
    Immunity. 1994 Sep;1(6):491-500 PMID: 7895159
  3. Interaction of MHC class I molecules with the transporter associated with antigen processing.
    Science. 1994 May 27;264(5163):1322-6 PMID: 8191286
  4. Localization of allodeterminants on H-2Kb antigens determined with monoclonal antibodies and H-2 mutant mice.
    Proc Natl Acad Sci U S A. 1982 Aug;79(15):4737-41 PMID: 6181513
  5. Increased tumorigenicity, but unchanged immunogenicity, of transporter for antigen presentation 1-deficient tumors.
    Cancer Res. 2002 May 15;62(10 ):2856-60 PMID: 12019164
  6. Downregulation of tapasin expression in progressive human malignant melanoma.
    Arch Dermatol Res. 2003 Jun;295(2):43-9 PMID: 12682852
  7. Mechanisms of exogenous antigen presentation by MHC class I molecules in vitro and in vivo: implications for generating CD8+ T cell responses to infectious agents, tumors, transplants, and vaccines.
    Adv Immunol. 1999;73:1-77 PMID: 10399005
  8. TAP associates with a unique class I conformation, whereas calnexin associates with multiple class I forms in mouse and man.
    J Immunol. 1995 Nov 15;155(10):4726-33 PMID: 7594473
  9. Functional deficiencies of components of the MHC class I antigen pathway in human tumors of epithelial origin.
    Bone Marrow Transplant. 2000 May;25 Suppl 2:S88-95 PMID: 10933198
  10. Quantitative and qualitative influences of tapasin on the class I peptide repertoire.
    J Immunol. 2001 Jan 15;166(2):1016-27 PMID: 11145681
  11. Characterization of class I MHC folding intermediates and their disparate interactions with peptide and beta 2-microglobulin.
    Mol Immunol. 1995 May;32(7):531-40 PMID: 7783756
  12. Calreticulin and calnexin interact with different protein and glycan determinants during the assembly of MHC class I.
    J Immunol. 1998 Jun 1;160(11):5404-9 PMID: 9605141
  13. Mechanisms of MHC class I--restricted antigen processing.
    Annu Rev Immunol. 1998;16:323-58 PMID: 9597133
  14. HLA-B27-restricted antigen presentation in the absence of tapasin reveals polymorphism in mechanisms of HLA class I peptide loading.
    Immunity. 1998 May;8(5):531-42 PMID: 9620674
  15. Immune escape of melanoma: first evidence of structural alterations in two distinct components of the MHC class I antigen processing pathway.
    Cancer Res. 2001 Dec 15;61(24):8647-50 PMID: 11751378
  16. Organ-specific pancreatic tumor growth properties and tumor immunity.
    Cancer Immunol Immunother. 1999 Jan;47(5):287-96 PMID: 10022473
  17. Cloning and functional characterization of a subunit of the transporter associated with antigen processing.
    Proc Natl Acad Sci U S A. 1997 Aug 5;94(16):8708-13 PMID: 9238042
  18. Does B7-1 expression confer antigen-presenting cell capacity to tumors in vivo?
    J Exp Med. 1996 Mar 1;183(3):769-76 PMID: 8642281
  19. Disparate binding of chaperone proteins by HLA-A subtypes.
    Immunogenetics. 2002 Feb;53(10-11):830-4 PMID: 11862383
  20. An extensive region of an MHC class I alpha 2 domain loop influences interaction with the assembly complex.
    J Immunol. 1999 Oct 15;163(8):4427-33 PMID: 10510384
  21. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy.
    Nature. 1986 Feb 20-26;319(6055):675-8 PMID: 3951539
  22. Impaired immune responses and altered peptide repertoire in tapasin-deficient mice.
    Nat Immunol. 2000 Sep;1(3):234-8 PMID: 10973281
  23. Monoclonal antibodies to mouse MHC antigens. II. Antibodies to the H-2Ld antigen, the products of a third polymorphic locus of the mouse major histocompatibility complex.
    J Immunol. 1980 Dec;125(6):2473-7 PMID: 7191868
  24. Molecular requirements for CD8-mediated rejection of a MUC1-expressing pancreatic carcinoma: implications for tumor vaccines.
    Cancer Immunol Immunother. 2002 Aug;51(6):327-40 PMID: 12111121
  25. MHC class I/beta 2-microglobulin complexes associate with TAP transporters before peptide binding.
    Nature. 1994 Apr 28;368(6474):864-7 PMID: 8159247
  26. Characterization of antigen processing machinery and Survivin expression in tonsillar squamous cell carcinoma.
    Cancer. 2003 May 1;97(9):2203-11 PMID: 12712472
  27. Summary report on the ISOBM TD-4 Workshop: analysis of 56 monoclonal antibodies against the MUC1 mucin. San Diego, Calif., November 17-23, 1996.
    Tumour Biol. 1998;19 Suppl 1:1-20 PMID: 9422084
  28. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens.
    Science. 1994 May 13;264(5161):961-5 PMID: 7513904
  29. Impaired assembly yet normal trafficking of MHC class I molecules in Tapasin mutant mice.
    Immunity. 2000 Aug;13(2):213-22 PMID: 10981964
  30. Downregulation of the constitutive tapasin expression in human tumor cells of distinct origin and its transcriptional upregulation by cytokines.
    Tissue Antigens. 2001 Jan;57(1):39-45 PMID: 11169257
  31. HLA-B polymorphism affects interactions with multiple endoplasmic reticulum proteins.
    Eur J Immunol. 2000 Oct;30(10 ):3021-8 PMID: 11069086
Article Info
Journal
Journal of clinical immunology
Abbr.
J Clin Immunol
ISSN
0271-9142
Published
2004-07-00
Pages
462-70
Language
English
Region
Netherlands
NLM ID
8102137
Subset
IM
Grants
NIGMS NIH HHS · GM 57428 · United States
NCI NIH HHS · P50 CA 72712 · United States
NCI NIH HHS · T32 CA 09476 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]